Technical Analysis for NVSEF - Novartis Ag Basl

Grade Last Price % Change Price Change
grade A 88.45 4.86% 4.1000
NVSEF closed up 4.86 percent on Friday, May 24, 2019, on 5 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NVSEF trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.86%
Crossed Above 200 DMA Bullish 4.86%

Older signals for NVSEF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, and established medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas; and finished dosage form anti-infective. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The company's Alcon segment offers intraocular lenses and equipment for cataract procedures; equipment, instruments, and devices for vitreoretinal surgeries; surgical equipment and diagnostic devices for refractive surgical procedures; and devices to treat glaucoma. It also provides viscoelastics, surgical solutions, diagnostic ophthalmic products, surgical packs, and other disposable products for cataract and vitreoretinal surgery. In addition, this segment offers contact lenses and ocular health products; over-the-counter ophthalmic products; eye drops for the temporary relief of ocular itching due to allergies; vitamins for ocular health; and iLux Device, a therapeutic device used to treat meibomian gland dysfunction. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Ligand Pharmaceuticals, Inc.; Amgen; University of California, Berkeley; Bristol-Myers Squibb; IBM Watson Health; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; PEAR Therapeutics; Pfizer; and Conatus Pharmaceuticals Inc. The company was founded in 1895 and is headquartered in Basel, Switzerland.
Medicine Health Biotechnology Healthcare Pharmaceuticals Pharmaceutical Industry In China Pain Surgery Healthcare Providers Healthcare Products Active Pharmaceutical Ingredients Neuroscience Antibiotics Ophthalmology Glaucoma Allergies Cataract Diagnostic Devices Medicine Products University Of California Biotechnology Based Products Hormonal Therapy Surgical Equipment
Is NVSEF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 96.5
52 Week Low 70.95
Average Volume 48,779
200-Day Moving Average 83.6752
50-Day Moving Average 86.6433
20-Day Moving Average 80.7899
10-Day Moving Average 82.4999
Average True Range 1.9223
ADX 23.05
+DI 45.8897
-DI 32.8524
Chandelier Exit (Long, 3 ATRs ) 82.6831
Chandelier Exit (Short, 3 ATRs ) 80.22689999999999
Upper Bollinger Band 86.9881
Lower Bollinger Band 74.5917
Percent B (%b) 1.12
BandWidth 15.343997
MACD Line -0.2901
MACD Signal Line -1.3739
MACD Histogram 1.0838
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 91.6900
Resistance 3 (R3) 91.3300 89.8900 91.1500
Resistance 2 (R2) 89.8900 89.0649 90.0700 90.9699
Resistance 1 (R1) 89.1700 88.5551 89.5300 89.5300 90.7899
Pivot Point 87.7300 87.7300 87.9100 87.9100 87.7300
Support 1 (S1) 87.0100 86.9049 87.3700 87.3700 86.1101
Support 2 (S2) 85.5700 86.3951 85.7500 85.9301
Support 3 (S3) 84.8500 85.5700 85.7500
Support 4 (S4) 85.2100